18 June 2013
Keywords: genvec, completes, 6m, stock, sale, biopharmaceutical, firm
Article | 26 April 2004
US biopharmaceutical firm GenVec has completed the sale of 4 million shares of its common stock at a price of $3.15 per ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.